Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of K-877 in dyslipidemia with type 2 diabetes mellitus
jRCT2080222362Phase 3
- Sponsor
- Kowa Company, Ltd.
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in dyslipidemia and type 2 diabetes mellitus (T2DM) comparing K-877 with Placebo (2 arms).
02
Drugs
pemafibrate
03
Conditions
dyslipidemiatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080222362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222362.